Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
ORIC Pharmaceuticals, Inc. Financials Banner

ORIC Pharmaceuticals, Inc. Financials

ORIC Stock Analysis

Page title

Section title

ORIC Income Statement Key Metrics

  • Revenue(TTM)1.54 M
  • Gross Profit(TTM)485,000
  • EBITDA(TTM)-124.59 M
  • Net Income(TTM)-110.78 M
  • EPS Diluted(TTM)-1.75

Decode ORIC's Latest Earnings Call with Ease

Tap 'Generate' for a crystal-clear,
AI-crafted summary and stay ahead in the investment game!

ORIC earnings and revenue history

ORIC Return on Equity

See how efficiently ORIC generates profit for it's shareholders.

-44.94%

10
0
100
  1. Poor

  2. Average

  3. Strong

Return on Equity vs Peers

Return on Equity ratio of ORIC (-0.449) is lower than the average of its peers (-0.369).

Return on Equity Growth

ORIC's Return on Equity has shown poor growth over the past 10 years, increasing by only -8.80%.

ORIC Revenue Growth

See how ORIC has grown it's revenue over the past 10 years.


Revenue Growth

ORIC's revenue has shown poor growth over the past 10 years, increasing by only 0%.

ORIC FY, 2023 Revenue Breakdown

See how ORIC converts it's revenue into profit.

ORIC Balance Sheet Health

ORIC Balance Sheet Breakdown 2023

Assets

  1. Long Term Assets

  2. Cash & Equivalents

  3. Inventory

  4. Receivables

  5. Property Plant Equipments

  6. Others

Liabilities

  1. Short Term Debt

  2. Long Term Debt

  3. Account Payables

  4. Others

ORIC financial position analysis

Short Term Liabilities

ORIC's short term assets($213M) can safely cover it's short term liabilities($20M).

Long Term Liabilities

ORIC's short term assets($213M) can safely cover it's long term liabilities($10M).

ORIC Debt to Equity